Login / Signup

Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.

Stephanie LienartRomain MerceronChristophe VanderaaFanny LambertDidier ColauJulie StockisBas van der WoningHans De HaardMichael SaundersPierre G CoulieSavvas N SavvidesSophie Lucas
Published in: Science (New York, N.Y.) (2018)
Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (Tregs) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by Tregs.
Keyphrases